These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36808782)

  • 1. The UK psychiatrists' experience of rationalising antipsychotics in adults with intellectual disabilities: A qualitative data analysis of free-text questionnaire responses.
    Shoumi Deb S; Limbu B; Nancarrow T; Gerrard D; Shankar R
    J Appl Res Intellect Disabil; 2023 May; 36(3):594-603. PubMed ID: 36808782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UK psychiatrists' experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism.
    Deb S; Nancarrow T; Limbu B; Sheehan R; Wilcock M; Branford D; Courtenay K; Perera B; Shankar R
    BJPsych Open; 2020 Sep; 6(5):e112. PubMed ID: 32938512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deprescribing psychotropic medicines for behaviours that challenge in people with intellectual disabilities: a systematic review.
    Adams D; Hastings RP; Maidment I; Shah C; Langdon PE
    BMC Psychiatry; 2023 Mar; 23(1):202. PubMed ID: 36978032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Prescribers.
    de Kuijper G; de Haan J; Deb S; Shankar R
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Experts by Experience.
    de Kuijper G; de Haan J; Deb S; Shankar R
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatrists' knowledge, training and attitudes regarding the care of individuals with intellectual disability.
    Werner S; Stawski M; Polakiewicz Y; Levav I
    J Intellect Disabil Res; 2013 Aug; 57(8):774-82. PubMed ID: 22974046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study.
    Henderson A; Mcskimming P; Kinnear D; McCowan C; McIntosh A; Allan L; Cooper SA
    BMJ Open; 2020 Sep; 10(9):e036862. PubMed ID: 32912946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey.
    Perry BI; Cooray SE; Mendis J; Purandare K; Wijeratne A; Manjubhashini S; Dasari M; Esan F; Gunaratna I; Naseem RA; Hoare S; Chester V; Roy A; Devapriam J; Alexander R; Kwok HF
    J Intellect Disabil Res; 2018 Feb; 62(2):140-149. PubMed ID: 29349928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telepsychiatry for people with intellectual disabilities and mental health difficulties during Covid-19 pandemic: survey of self-reported experience and acceptability to patients, carers and psychiatrists in the UK.
    Gates B; Sawhney I; Alexander R; Shardlow S; Zia A
    Int J Dev Disabil; 2024; 70(4):749-755. PubMed ID: 38983500
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic testing in intellectual disability psychiatry: Opinions and practices of UK child and intellectual disability psychiatrists.
    Wolfe K; Stueber K; McQuillin A; Jichi F; Patch C; Flinter F; Strydom A; Bass N
    J Appl Res Intellect Disabil; 2018 Mar; 31(2):273-284. PubMed ID: 28833975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A structured programme to withdraw antipsychotics among adults with intellectual disabilities: The Cornwall experience.
    Shankar R; Wilcock M; Deb S; Goodey R; Corson E; Pretorius C; Praed G; Pell A; Vujkovic D; Wilkinson E; Laugharne R; Axby S; Sheehan R; Alexander R
    J Appl Res Intellect Disabil; 2019 Nov; 32(6):1389-1400. PubMed ID: 31192534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The views of psychiatrists on proposed changes to the England and Wales Mental Health Act 1983 legislation for people with intellectual disability: A national study.
    Tromans S; Robinson G; Gabrielsson A; Bassett P; Sawhney I; Triantafyllopoulou P; Hassiotis A; Shankar R
    Int J Soc Psychiatry; 2024 Mar; 70(2):388-401. PubMed ID: 38001564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of psychotropic medication and factors associated with antipsychotic treatment in adults with intellectual disabilities: a cross-sectional, epidemiological study in Germany.
    Koch AD; Dobrindt J; Schützwohl M
    J Intellect Disabil Res; 2021 Feb; 65(2):186-198. PubMed ID: 33393123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences of psychotropic medication use and decision-making for adults with intellectual disability: a multistakeholder qualitative study in the UK.
    Sheehan R; Hassiotis A; Strydom A; Morant N
    BMJ Open; 2019 Nov; 9(11):e032861. PubMed ID: 31780594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The psychiatric care of people with intellectual disabilities: the perceptions of trainee psychiatrists and psychiatric medical officers.
    Lennox N; Chaplin R
    Aust N Z J Psychiatry; 1995 Dec; 29(4):632-7. PubMed ID: 8825826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot randomised controlled trial of community-led ANtipsychotic Drug REduction for Adults with Learning Disabilities.
    McNamara R; Randell E; Gillespie D; Wood F; Felce D; Romeo R; Angel L; Espinasse A; Hood K; Davies A; Meek A; Addison K; Jones G; Deslandes P; Allen D; Knapp M; Thapar A; Kerr M
    Health Technol Assess; 2017 Aug; 21(47):1-92. PubMed ID: 28857740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the use of Antipsychotic Medication in an Intellectual Disability (ID) community caseload.
    Thalitaya MD; Reynolds C; Ismail I
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):578-583. PubMed ID: 28953833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The psychiatric care of people with intellectual disabilities: the perceptions of consultant psychiatrists in Victoria.
    Lennox N; Chaplin R
    Aust N Z J Psychiatry; 1996 Dec; 30(6):774-80. PubMed ID: 9034466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.